Liver Transplantation Quality Measures

A successful organ transplant depends on appropriate evaluation of the organ recipient, expertise in the surgical procedures required to transplant the organ and on-going monitoring after transplant to prevent organ rejection or infections.

To measure the quality of care provided to liver transplant patients, Cedars-Sinai Medical Center examines one-month, one-year and three-year survival rates.

The table below shows key outcome measurements for liver transplants done at Cedars-Sinai Medical Center. Both the numbers and percentages of liver transplant patients surviving one month, one year and three years are highlighted. These statistics reflect adult patients age 18 and older who had their first liver transplant. Patients who were having other organs transplanted at the same time (multiple organ transplantation) are not included.

The one-month and one-year survival rates reflect patients receiving their first transplant between July 1, 2008, and December 31, 2010. The three-year survival rates reflect patients receiving their first transplant between January 1, 2006 and June 30, 2008. These data are reported to the Scientific Registry of Transplant Recipients.

Liver Transplant* (Adults Age 18+)	Cedars-Sinai Medical Center
Patient Survival for:	1 Month	1 Year	3 Years
For transplants done	July 2008 - Dec 2010	July 2008 - Dec 2010	Jan 2006 - June 2008
Number of transplants	105	105	102
Percent of patients surviving at the end of the period observed**	98.10%	92.38%	85.29%
Expected survival rate for patients of similar ages,blood type and health condition***	96.33%	87.02%	82.53%
Cedars-Sinai's survival rates compared to what is expected for similar patients	Not significantly different	Not significantly different	Not significantly different

*These statistics reflect patients who had their first liver transplant. They do not include anyone who had a multiple organ transplant.

** Observed survival rates use the Kaplan-Meier method to estimate outcomes for patients for whom complete follow-up is not expected. Because different cohorts are followed for each time period, it is possible for the reported three-year survival to exceed one-year survival

*** The survival rate that would be expected for the patients survived by the transplant center, given the demographics and risk factors of the recipient and donor (e.g., age, disease and blood type, etc.) and the experience of similar patients in the United States as a whole.